Refining drug-eluting stent technologies: from engineering to basic science
(Source: European Heart Journal)
Source: European Heart Journal - February 24, 2021 Category: Cardiology Source Type: research
Tilt testing remains a valuable asset
AbstractHead-up tilt test (TT) has been used for>50 years to study heart rate/blood pressure adaptation to positional changes, to model responses to haemorrhage, to assess orthostatic hypotension, and to evaluate haemodynamic and neuroendocrine responses in congestive heart failure, autonomic dysfunction, and hypertension. During these studies, so me subjects experienced syncope due to vasovagal reflex. As a result, tilt testing was incorporated into clinical assessment of syncope when the origin was unknown. Subsequently, clinical experience supports the diagnostic value of TT. This is highlighted in evidence-based ...
Source: European Heart Journal - February 24, 2021 Category: Cardiology Source Type: research
All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study
ConclusionsAmong patients with established cardiovascular disease, the in-hospital mortality rate was lower and out-of-hospital mortality rate higher during lockdown compared with the same period in the preceding year, irrespective of age and sex. (Source: European Heart Journal)
Source: European Heart Journal - February 24, 2021 Category: Cardiology Source Type: research
The collateral cardiovascular damage of COVID-19: only history will reveal the depth of the iceberg
(Source: European Heart Journal)
Source: European Heart Journal - February 24, 2021 Category: Cardiology Source Type: research
Glucocorticoids in patients with immune-mediated inflammatory diseases: a neglected cardiovascular risk factor
Comment on “Dose-dependent oral glucocorticoid cardiovascular risks in people with immunemediated inflammatory diseases: a population-based cohort study” is available onPLoS Medicine (Source: European Heart Journal)
Source: European Heart Journal - February 22, 2021 Category: Cardiology Source Type: research
Cardiac events associated with immune checkpoint inhibitor therapy: the devil is in the detail
This commentary refers to the article ‘The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study’, by M. D'Souzaet al., doi:10.1093/eurheartj/ehaa884 and the discussion piece ‘Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer’, by M. D’Souzaet al., doi:10.1093/eurheartj/ehab066. (Source: European Heart Journal)
Source: European Heart Journal - February 21, 2021 Category: Cardiology Source Type: research
Immune check point inhibitors are associated with a spectrum of cardiac events in patients with cancer
This commentary refers to the article ‘The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study’, by M. D’Souzaet al., doi:10.1093/eurheartj/ehaa884 and the discussion piece ‘Cardiac events associated with ICI therapy—the devil is in the detail’, by M.S. Ankeret al., doi:10.1093/eurheartj/ehab063. (Source: European Heart Journal)
Source: European Heart Journal - February 21, 2021 Category: Cardiology Source Type: research
Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
ConclusionsDuring convalescence after severe COVID-19 infection with troponin elevation, myocarditis-like injury can be encountered, with limited extent and minimal functional consequence. In a proportion of patients, there is evidence of possible ongoing localized inflammation. A quarter of patients had ischaemic heart disease, of which two-thirds had no previous history. Whether these observed findings represent pre-existing clinically silent disease orde novo COVID-19-related changes remain undetermined. Diffuse oedema or fibrosis was not detected. (Source: European Heart Journal)
Source: European Heart Journal - February 18, 2021 Category: Cardiology Source Type: research
Corrigendum to: 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
[Eur Heart J 2020; doi:10.1093/eurheartj/ehaa575] (Source: European Heart Journal)
Source: European Heart Journal - February 18, 2021 Category: Cardiology Source Type: research
Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?
This commentary refers to the article ‘Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study’, by J. Schroderet al., doi:10.1093/eurheartj/ehaa944 and the discussion piece ‘Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis’, by J. Schroder and E. Prescott, doi:10.1093/eurheartj/ehab064. (Source: European Heart Journal)
Source: European Heart Journal - February 17, 2021 Category: Cardiology Source Type: research
Coronary flow velocity reserve adds prognostic information beyond presence or absence of non-obstructive coronary atherosclerosis
This commentary refers to the article ‘Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study’, by J. Schroderet al., doi:10.1093/eurheartj/ehaa944 and the discussion piece ‘Is coronary flow velocity reserve just a marker of a higher atherosclerotic burden?’, by F. Radicoet al., doi:10.1093/eurheartj/ehab062. (Source: European Heart Journal)
Source: European Heart Journal - February 17, 2021 Category: Cardiology Source Type: research
Quality of life in EMPEROR-Reduced: emphasizing what is important to patients while identifying strategies to support more patient-centred care
(Source: European Heart Journal)
Source: European Heart Journal - February 17, 2021 Category: Cardiology Source Type: research
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
This commentary refers to the article ‘Brugada syndrome genetics is associated with phenotype severity’ by G. Ciconteet al., doi:10.1093/eurheartj/ehaa942 and the discussion piece ‘Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside’ by I El-Battrawyet al., doi:10.1093/eurheartj/ehab070. (Source: European Heart Journal)
Source: European Heart Journal - February 17, 2021 Category: Cardiology Source Type: research
Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside
This commentary refers to ‘Brugada syndrome genetics is associated with phenotype severity’ by G. Ciconteet al., doi:10.1093/eurheartj/ehaa942 and the discussion piece ‘Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value’ by C. Papponeet al., doi:10.1093/eurheartj/ehab071. (Source: European Heart Journal)
Source: European Heart Journal - February 17, 2021 Category: Cardiology Source Type: research
Air pollution and flooding in the lungs: modern insights into ancient problems
This editorial refers to ‘Joint exposure to various ambient air pollutants and incident heart failure: a prospective analysis in UK Biobank’††, by M. Wang et al., on page1852. (Source: European Heart Journal)
Source: European Heart Journal - February 16, 2021 Category: Cardiology Source Type: research
